المؤلفون: Kumar, S, Giralt, S, Stadtmauer, Ea, Harousseau, Jl, Palumbo, Antonio, Bensinger, W, Comenzo, Rl, Lentzsch, S, Munshi, N, Niesvizky, R, San Miguel, J, Ludwig, H, Bergsagel, L, Blade, J, Lonial, S, Anderson, Kc, Tosi, P, Sonneveld, P, Sezer, O, Vesole, D, Cavo, M, Einsele, H, Richardson, Pg, Durie, Bg, Rajkumar, Sv, International Myeloma Working Group

المساهمون: Radiology & Nuclear Medicine, Hematology, Kumar S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Lentzsch S, Munshi N, Niesvizky R, San Miguel J, Ludwig H, Bergsagel L, Blade J, Lonial S, Anderson KC, Tosi P, Sonneveld P, Sezer O, Vesole D, Cavo M, Einsele H, Richardson PG, Durie BG, Rajkumar SV, International Myeloma Working Group.

المصدر: Blood, 114(9), 1729-1735. American Society of Hematology

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Consensus Development Conferences as Topic, medicine.medical_treatment, Immunology, Antineoplastic Agents, Hematopoietic stem cell transplantation, Medical Oncology, Biochemistry, Bortezomib, Autologous stem-cell transplantation, Internal medicine, medicine, Humans, Lenalidomide, Multiple myeloma, Hematopoietic Stem Cell Mobilization, Clinical Trials as Topic, business.industry, Hematopoietic Stem Cell Transplantation, Cell Biology, Hematology, medicine.disease, Boronic Acids, Combined Modality Therapy, Thalidomide, Pyrazines, Stem cell, Multiple Myeloma, business, Immunosuppressive Agents, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d4e2b9acf06cf934693ee79b02e3f0Test
https://pure.eur.nl/en/publications/c37dbdad-e9fe-4602-9985-9ff0a3ac0918Test

المؤلفون: Jean-Yves Mary, Mamoun Dib, Gaelle Guillerm, Jérôme Jaubert, C Chaleteix, H. Maisonneuve, Thierry Facon, Jacques Troncy, M. Monconduit, Lotfi Benboubker, M. Attal, Brigitte Kolb, C. Hulin, Francis Bauters, Harousseau Jl, Claude Martin, Philippe Casassus, H. Jardel, Brigitte Pegourie, Véronique Dorvaux, Marc Renaud, Laurent Voillat

المصدر: Blood. 106:780-780

مصطلحات موضوعية: Melphalan, medicine.medical_specialty, Randomization, business.industry, Proportional hazards model, Immunology, Hazard ratio, Urology, Cell Biology, Hematology, Interim analysis, Biochemistry, Confidence interval, Surgery, Thalidomide, Autologous stem-cell transplantation, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::32e3ddb2b727921391437c6ee8e3f4feTest
https://doi.org/10.1182/blood.v106.11.780.780Test

المؤلفون: Jerome B. Zeldis, Harousseau Jl, Andrew Spencer, Robert Knight, M. Attal, Meletios A. Dimopoulos, Marta Olesnyckyj, Anna Dmoszynska, Zhinuan Yu, Miles Prince

المصدر: Blood. 106:6-6

مصطلحات موضوعية: medicine.medical_specialty, Combination therapy, business.industry, Immunology, Phases of clinical research, Cell Biology, Hematology, Neutropenia, medicine.disease, Interim analysis, Placebo, Biochemistry, Gastroenterology, Internal medicine, medicine, business, hormones, hormone substitutes, and hormone antagonists, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::55b58ba77645cbe11902b5337326618cTest
https://doi.org/10.1182/blood.v106.11.6.6Test

المؤلفون: Vanessa Bolejack, Michel Attal, Meletios A. Dimopoulos, Jesús F. San Miguel, Douglas E. Joshua, Pieter Sonneveld, Rafael Fonseca, Robert A. Kyle, Bart Barlogie, Joan Bladé, Chaim Shustik, Michele Cavo, Jan Westin, Heinz Ludwig, Kazuyuki Shimizu, Antonio Palumbo, John Crowley, Mario Boccadoro, Brian G.M. Durie, Philip R. Greipp, Meral Beksac, Ingemar Turesson, Jean Luc Harousseau

المساهمون: Radiology & Nuclear Medicine, Hematology, Ludwig H, Durie BG, Bolejack V, Turesson I, Kyle RA, Blade J, Fonseca R, Dimopoulos M, Shimizu K, San Miguel J, Westin J, Harousseau JL, Beksac M, Boccadoro M, Palumbo A, Barlogie B, Shustik C, Cavo M, Greipp PR, Joshua D, AttalM, Sonneveld P, Crowley J.

المصدر: Blood, 111(8), 4039-4047. American Society of Hematology

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Clinical Trials and Observations, International Cooperation, Immunology, Biochemistry, Age Distribution, Risk Factors, Internal medicine, medicine, Autologous transplantation, Humans, Stage (cooking), Risk factor, Survival rate, Survival analysis, Multiple myeloma, Aged, Aged, 80 and over, Hematology, biology, business.industry, C-reactive protein, Cell Biology, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Surgery, Cytogenetic Analysis, Multivariate Analysis, biology.protein, Female, business, Multiple Myeloma

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996cd52b4fc5678ac74fbf607805ec9fTest
https://hdl.handle.net/1765/29132Test

المؤلفون: Pieter Sonneveld, Carolina Terragna, Norma C. Gutiérrez, Hartmut Goldschmidt, Maria Luisa Martin, Hans Salwender, Gerald Marit, Wolgang Igor Blau, Henk M. Lokhorst, Francesca Patriarca, Jesús F. San Miguel, Giulia Marzocchi, Jean-Luc Harousseau, Laura Rosiñol, Michel Attal, Antonio Palumbo, Joan Bladé, Bronno van der Holt, Maria Teresa Petrucci, Thierry Facon, Juan José Lahuerta, Michele Cavo, Hervé Avet-Loiseau, Philippe Moreau

المساهمون: Cavo, M, Sonneveld, P, Moreau, P, Blade, J, Goldschmidt, H, San Miguel, JF, Attal, M, Avet-Loiseau, H, Blau, WI, Facon, T, Gutierrez, N, Harousseau, JL, van der Holt, B, Jose Lahuerta, J, Lokhorst, H, Marit, G, Luisa Martin, M, Marzocchi, G, Palumbo, A, Patriarca, F, Petrucci, MT, Rosinol, L, Salwender, H, Terragna, C

مصطلحات موضوعية: education.field_of_study, medicine.medical_specialty, Bortezomib, business.industry, Immunology, Population, Cell Biology, Hematology, Newly diagnosed, Biochemistry, Family medicine, medicine, Cooperative group, education, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6a875f8d36b82f0f992ed8f45d6c33Test
http://hdl.handle.net/11585/396505Test

المؤلفون: Paul G. Richardson, Helgi van de Velde, Jean-Luc Harousseau, Dixie-Lee Esseltine, Rudolf Schlag, Maria-Victoria Mateos, Antonio Palumbo, Ofer Shpilberg, Andrew Cakana, Kevin Liu, Jesús F. San Miguel, Alain Kentos, Anatoly Golenkov, Meletios A. Dimopoulos, Martin Kropff, Mieczysław Komarnicki, Michele Cavo, William Deraedt

المساهمون: Harousseau JL, Palumbo A, Richardson PG, Schlag R, Dimopoulos MA, Shpilberg O, Kropff M, Kentos A, Cavo M, Golenkov A, Komarnicki M, Mateos MV, Esseltine DL, Cakana A, Liu K, Deraedt W, van de Velde H, San Miguel JF.

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: Melphalan, Male, medicine.medical_specialty, Time Factors, medicine.drug_class, Immunology, Urology, Kaplan-Meier Estimate, Biochemistry, Bortezomib, chemistry.chemical_compound, Prednisone, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multiple myeloma, Aged, Very Good Partial Response, business.industry, Hazard ratio, Remission Induction, Cell Biology, Hematology, Middle Aged, medicine.disease, Prognosis, Boronic Acids, Nitrogen mustard, Surgery, Treatment Outcome, chemistry, Pyrazines, Multivariate Analysis, Corticosteroid, Female, business, Multiple Myeloma, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b7575c14625ec3fee0597f02beab88Test
http://hdl.handle.net/10261/63102Test

المؤلفون: Harousseau, Jean-Luc, Martinelli, Giovanni, Jedrzejczak, Wieslaw W, Brandwein, Joseph M, Bordessoule, Dominique, Masszi, Tamas, Ossenkoppele, Gert J, Alexeeva, Julia A, Beutel, Gernot, Maertens, Johan, Vidriales, Maria-Belen, Dombret, Hervé, Thomas, Xavier, Burnett, Alan K, Robak, Tadeusz, Khuageva, Nuriet K, Golenkov, Anatoly K, Tothova, Elena, Mollgard, Lars, Park, Youn C, Bessems, Annick, De Porre, Peter, Howes, Angela J, Renseigné, Non

المساهمون: Service d'Hématologie clinique et thérapie cellulaire [CHU Limoges], CHU Limoges, Service d'Hématologie biologique [CHU Limoges], Université de Limoges (UNILIM), Physiologie Moléculaire de la Réponse Immune et des Lymphoproliférations (PMRIL), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Centre National de la Recherche Scientifique (CNRS), Lymphocyte et cancer, IFR105-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique, immunothérapie, chimie et cancer (GICC), UMR 6239 CNRS [2008-2011] (GICC UMR 6239 CNRS), Université de Tours-Centre National de la Recherche Scientifique (CNRS), Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Harousseau JL, Martinelli G, Jedrzejczak WW, Brandwein JM, Bordessoule D, Masszi T, Ossenkoppele GJ, Alexeeva JA, Beutel G, Maertens J, Vidriales MB, Dombret H, Thomas X, Burnett AK, Robak T, Khuageva NK, Golenkov AK, Tothova E, Mollgard L, Park YC, Bessems A, De Porre P, Howes AJ., Hematology, CCA - Innovative therapy

المصدر: Harousseau, J L, Martinelli, G, Jedrzejczak, W W, Brandwein, J M, Bordessoule, D, Masszi, T, Ossenkoppele, G J, Alexeeva, J A, Beutel, G, Maertens, J, Vidriales, M B, Dombret, H, Thomas, X, Burnett, A K, Robak, T, Khuageva, N K, Golenkov, A K, Tothova, E, Mollgard, L, Park, Y, Bessems, A, De Porre, P & Howes, A J 2009, ' A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older ', Blood, vol. 114, no. 6, pp. 1166-1173 . https://doi.org/10.1182/blood-2009-01-198093Test
Blood
Blood, American Society of Hematology, 2009, 114 (6), pp.1166-73. ⟨10.1182/blood-2009-01-198093⟩
Blood, 114(6), 1166-1173. American Society of Hematology

مصطلحات موضوعية: Male, Time Factors, Administration, Oral, Phases of clinical research, Quinolones, TIPIFARNIB, Biochemistry, 0302 clinical medicine, MESH: Aged, 80 and over, Clinical endpoint, Hydroxyurea, Secondary Acute Myeloid Leukemia, Aged, 80 and over, MESH: Aged, 0303 health sciences, Hazard ratio, Hematology, MESH: Hydroxyurea, 3. Good health, Survival Rate, Leukemia, Myeloid, Acute, 030220 oncology & carcinogenesis, MESH: Administration, Oral, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, MESH: Leukemia, Myeloid, Acute, medicine.drug, medicine.medical_specialty, Neutropenia, MESH: Neutropenia, MESH: Survival Rate, Immunology, Antineoplastic Agents, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, ACUTE MYELOID LEUKEMIA (AML), Survival rate, Aged, 030304 developmental biology, MESH: Humans, MESH: Quinolones, business.industry, MESH: Time Factors, Cell Biology, medicine.disease, MESH: Male, Surgery, MESH: Disease-Free Survival, MESH: Antineoplastic Agents, Tipifarnib, business, MESH: Female, Febrile neutropenia

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c75c4c64781116ccf47026aa553bf0fTest
http://hdl.handle.net/11573/32513Test